Helix Holdings II LLC - Aug 11, 2025 SCHEDULE 13D/A Report for BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

Filing Manager
Helix Holdings II LLC
Reporting Manager
Bihua Chen
Security
BridgeBio Oncology Therapeutics, Inc. Common Stock
Symbol
BBOT
Shares outstanding
79.1M shares
Disclosed Ownership
17.9M shares
Ownership
22.6%
Form type
SCHEDULE 13D/A
Date filed
8/13/2025, 08:29 AM
Date of event
Aug 11, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Helix Holdings II LLC 5.7% 4.53M 4.53M 0 /s/ Bihua Chen Bihua Chen, Managing Member 0001869101
Cormorant Global Healthcare Master Fund, LP 7.5% 5.95M 5.95M 0 /s/ Bihua Chen Bihua Chen, Managing Member of Cormorant Global Healthcare GP, LLC 0001618442
Cormorant Global Healthcare GP, LLC 7.5% 5.95M 5.95M 0 /s/ Bihua Chen Bihua Chen, Managing Member 0001618451
Bihua Chen 22.6% 17.9M 17.9M 0 /s/ Bihua Chen Bihua Chen, Self 0001599214